Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Soodaeva, T. Li, I. Klimanov, L. Postnikova, N. Kubysheva, O. Mironova, A. Fedin (Moscow, Nizhny Novgorod, Russian Federation). The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD). Eur Respir J 2013; 42: Suppl. 57, 646

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction? Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Nitric oxide metabolism in COPD comorbidities Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Temporal stability of feno measurement in COPD Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016 Nitric oxide in COPD patients saliva as marker of oxidative stress Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Association of free radical formation, severity of disease and degree of systemic inflammation in patients with bronchial asthma Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008